Literature DB >> 12799308

Increasing cell membrane potential and GABAergic activity inhibits malignant hepatocyte growth.

D Sun1, Y Gong, H Kojima, G Wang, E Ravinsky, M Zhang, G Y Minuk.   

Abstract

Increasing hepatocyte membrane potentials by augmenting GABAergic activity inhibits nonmalignant hepatocyte proliferative activity. The objectives of this study were to document 1) potential differences (PDs) of four malignant hepatocyte cell lines, 2) GABAA receptor mRNA expression in the same cell lines, and 3) effects of restoring malignant hepatocyte PDs to levels approximating those of resting, nonmalignant hepatocytes. Hepatocyte PDs were documented in nonmalignant and malignant (Chang, HepG2, HuH-7, and PLC/PRF/5) hepatocytes with a fluorescent voltage-sensitive dye and GABAA receptor expression by RT-PCR and Western blot analyses. Compared with nonmalignant human hepatocytes, all four malignant cell lines were significantly depolarized (P < 0.0001, respectively). Only PLC/PRF/5 cells had detectable GABAA-beta3 receptor mRNA expression and all cell lines were negative for GABAA-beta3 receptor protein by Western blot analysis. Stable transfection of Chang cells with GABAA-beta3 receptor cDNA resulted in significant increases in PD and decreases in proliferative activity as manifest by decreased [3H]thymidine and bromodeoxyurieine incorporation rates, 4-[3-(4-lodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate activity, a lower mitotic index, prolongation of cell-doubling times, and attenuated growth patterns compared with cells transfected with vector alone. Colony formation in soft agar and the number of abnormal mitoses were also significantly decreased in GABAA-beta3 receptor transfected cells. The results of this study indicate 1) relative to healthy hepatocytes, malignant hepatocytes are significantly depolarized, 2) GABAA-beta3 receptor expression is absent in malignant hepatocyte cell lines, and 3) increasing the PD of malignant hepatocytes is associated with less proliferative activity and a loss of malignant features.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12799308     DOI: 10.1152/ajpgi.00513.2002

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  10 in total

1.  GABA, γ-Aminobutyric Acid, Protects Against Severe Liver Injury.

Authors:  Toshiyuki Hata; Fatima Rehman; Tomohide Hori; Justin H Nguyen
Journal:  J Surg Res       Date:  2018-12-17       Impact factor: 2.192

2.  Gamma-aminobutyric acid promotes human hepatocellular carcinoma growth through overexpressed gamma-aminobutyric acid A receptor alpha 3 subunit.

Authors:  Yan Liu; Yue-Hui Li; Feng-Jie Guo; Jia-Jia Wang; Rui-Li Sun; Jin-Yue Hu; Guan-Cheng Li
Journal:  World J Gastroenterol       Date:  2008-12-21       Impact factor: 5.742

3.  The intermediate conductance calcium-activated potassium channel KCa3.1 regulates vascular smooth muscle cell proliferation via controlling calcium-dependent signaling.

Authors:  Dan Bi; Kazuyoshi Toyama; Vincent Lemaître; Jun Takai; Fan Fan; David P Jenkins; Heike Wulff; David D Gutterman; Frank Park; Hiroto Miura
Journal:  J Biol Chem       Date:  2013-04-22       Impact factor: 5.157

4.  GABAA receptors are expressed and facilitate relaxation in airway smooth muscle.

Authors:  Kentaro Mizuta; Dingbang Xu; Yaping Pan; George Comas; Joshua R Sonett; Yi Zhang; Reynold A Panettieri; Jay Yang; Charles W Emala
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-04-11       Impact factor: 5.464

5.  High expression of neuro-oncological ventral antigen 1 correlates with poor prognosis in hepatocellular carcinoma.

Authors:  Yi-An Zhang; Ji-Min Zhu; Jie Yin; Wen-Qing Tang; Yan-Mei Guo; Xi-Zhong Shen; Tao-Tao Liu
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

6.  RNA binding protein Nova1 promotes tumor growth in vivo and its potential mechanism as an oncogene may due to its interaction with GABAA Receptor-γ2.

Authors:  Yi-An Zhang; Hai-Ning Liu; Ji-Min Zhu; Dan-Ying Zhang; Xi-Zhong Shen; Tao-Tao Liu
Journal:  J Biomed Sci       Date:  2016-10-12       Impact factor: 8.410

7.  Magnetoelectric core-shell CoFe2O4@BaTiO3 nanorods: their role in drug delivery and effect on multidrug resistance pump activity in vitro.

Authors:  Sadaf Mushtaq; Khuram Shahzad; Muhammad Rizwan; Anwar Ul-Hamid; Bilal Haider Abbasi; Waqas Khalid; Muhammad Atif; Nafees Ahmad; Zulqurnain Ali; Rashda Abbasi
Journal:  RSC Adv       Date:  2022-09-01       Impact factor: 4.036

8.  Metabolomic Analysis of Liver Tissue from the VX2 Rabbit Model of Secondary Liver Tumors.

Authors:  R Ibarra; J-E Dazard; Y Sandlers; F Rehman; R Abbas; R Kombu; G-F Zhang; H Brunengraber; J Sanabria
Journal:  HPB Surg       Date:  2014-03-02

9.  Loss of ABAT-Mediated GABAergic System Promotes Basal-Like Breast Cancer Progression by Activating Ca2+-NFAT1 Axis.

Authors:  Xingyu Chen; Qianhua Cao; Ruocen Liao; Xuebiao Wu; Shining Xun; Jian Huang; Chenfang Dong
Journal:  Theranostics       Date:  2019-01-01       Impact factor: 11.556

10.  Hepatocyte membrane potential regulates serum insulin and insulin sensitivity by altering hepatic GABA release.

Authors:  Caroline E Geisler; Susma Ghimire; Chelsea Hepler; Kendra E Miller; Stephanie M Bruggink; Kyle P Kentch; Mark R Higgins; Christopher T Banek; Jun Yoshino; Samuel Klein; Benjamin J Renquist
Journal:  Cell Rep       Date:  2021-06-29       Impact factor: 9.423

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.